| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |